{"id":"W3212046139","doi":"10.1182/blood-2021-152750","title":"Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with High-Risk and Relapsed/Refractory Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Medicine; Myeloid leukemia; Internal medicine; Leukemia; Oncology; Induction therapy; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000586773,0.0005246921,0.0009003986,0.0002342457,0.0001801602,0.0004390765,0.0004291488,0.0005123851,0.00181401],"category_scores_gemma":[0.0007800511,0.0002055906,0.0005160059,0.0002517008,0.0004403054,0.0004220152,0.0002055734,0.001705951,0.0003765338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006835545,"about_ca_system_score_gemma":0.0006867059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004576417,"about_ca_topic_score_gemma":0.001234788,"domain_scores_codex":[0.9997737,0.00009668989,0.00001367379,0.00004792846,0.00003070356,0.00003728619],"domain_scores_gemma":[0.9995546,0.00009845721,0.0001277093,0.00003771723,0.00001829839,0.0001630926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5224386,0.02766774,0.02717065,0.0007052224,0.0009706852,0.0002679364,0.0002050282,0.003748497,0.06530055,0.0002501129,0.002181972,0.3490931],"study_design_scores_gemma":[0.1925426,0.6340679,0.1455373,0.00009916951,0.001182298,0.0007590904,0.0000652559,0.003970766,0.01565067,0.0004142171,0.0056476,0.00006306315],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975268,0.001161272,0.0001824384,0.000122252,0.00001895846,0.0001757653,0.0001774272,0.00003385631,0.0006013727],"genre_scores_gemma":[0.9974636,0.0006396121,0.0004619084,0.0002243668,0.00004169255,0.0002128929,0.0004479827,0.000006700482,0.0005012405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00181401,"threshold_uncertainty_score":0.006068468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007087328058147671,"score_gpt":0.2221011352718281,"score_spread":0.2150138072136805,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}